A widely used intervention to reduce drug name mix-ups hasn’t significantly reduced errors involving 11 pairs of commonly confused pediatric drugs, according to a study in a leading health care improvement journal (BMJ Qual Saf 2016;25[4]:233-240).
The study is among the first to assess the effects of a widely used drug safety measure, called tall man lettering, in a large clinical sample. It found that there hasn’t been a substantial drop in drug name mix-ups